Evidence map›Paper›PMID 33617514›Full record

ArticleCurrent oncology (Toronto, Ont.)2021

Incidence and Mortality of Prostate Cancer in Canada during 1992-2010.

François Lagacé, Feras M Ghazawi, Michelle Le, Evgeny Savin, Andrei Zubarev, Mathieu Powell, Linda Moreau, Denis Sasseville, Ioana Popa, Ivan V Litvinov

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Assessment of the epidemiological trends for prostate cancer using administrative data in Ontario.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  4. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  5. Article
  6. Prostate cancer screening in Black men in Canada: a case for risk-stratified care.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

François LagacéDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.ORCID 0000-0002-9033-2302
Feras M GhazawiDepartment of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.ORCID 0000-0001-5848-128X
Michelle LeDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Evgeny SavinDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Andrei ZubarevDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Mathieu PowellDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Linda MoreauDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Denis SassevilleDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Ioana PopaDivision of Urologic Surgery, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Ivan V LitvinovDepartment of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.ORCID 0000-0003-0562-4675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze demographic data on Canadian men diagnosed with prostate cancer and men who died of prostate cancer between the years of 1992 and 2010. The incidence and mortality rates were calculated at the provincial, city, and forward sortation area (FSA) postal code levels by using population counts that were obtained from the Canadian Census of Population. The Canadian average incidence rate was 113.57 cases per 100,000 males. There has been an overall increasing trend in crude prostate cancer incidence between 1992 and 2010 with three peaks, in 1993, 2001, and 2007. However, age-adjusted incidence rates showed no significant increase over time. The national mortality rate was calculated to be 24.13 deaths per 100,000 males per year. A decrease was noted in crude and age-adjusted mortality rates between 1992 and 2010. Several provinces, cities, and FSAs had higher incidence/mortality rates than the national average. Several of the FSA postal codes with the highest incidence/mortality rates were adjacent to one another. Several Canadian regions of high incidence for prostate cancer have been identified through this study and temporal trends are consistent with those reported in the literature. These results will serve as a foundation for future studies that will seek to identify new regional risk factors and etiologic agents.

Indexed as

Prostatic NeoplasmsCanadaHumansIncidenceMaleRetrospective StudiesRisk FactorsCanadaepidemiologyincidencemortalityprostate cancer

Identifiers

PMID33617514
PMCPMC7985768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.